Summary
Cardinal Health, Inc. (CAH) filed an 8-K on February 3, 2012, to disclose actions taken by the U.S. Drug Enforcement Administration (DEA) at the company's Lakeland, Florida distribution center. While the filing itself does not detail the nature of these actions, it states that a press release, included as an exhibit, provides further information. This event is significant for investors as it indicates potential operational disruptions or legal/regulatory scrutiny related to a key distribution facility. The company also announced a conference call scheduled for the same day to discuss the DEA's actions, suggesting they will provide more context and potential impact to stakeholders.
Key Highlights
- 1Cardinal Health disclosed actions by the Drug Enforcement Administration (DEA) at its Lakeland, Florida distribution center.
- 2The filing was made on February 3, 2012, reporting an event date of February 2, 2012.
- 3A press release detailing the DEA's actions is included as an exhibit to the 8-K filing.
- 4The company scheduled a conference call for February 3, 2012, to discuss the DEA's actions.
- 5This disclosure suggests potential operational or legal/regulatory issues impacting the company's distribution network.